Table 2.
Clinical Features | Overall Survival | |
---|---|---|
Hazard Ratio (95% CI) | p | |
Presence of JAK2V17F | 3.8620 (1.32–11.30) | 0.01365 |
Overt MF | 0.5023 (0.19–1.36) | 0.17510 |
Circulating CD34+ cells (Log10) | 1.7490 (1.05–2.90) | 0.03063 |
LDH > 1000 nM | 2.2210 (0.77–6.39) | 0.13910 |
High TAC classification | 2.8910 (1.18–7.1) | 0.006838 |